Figure 3.

OS curves and P-values (log-rank test) for comparisons among patients with no residual tumour (Group I), those with BMI1-negative tumours (Group II), patients with no residual tumour and those with BMI1-negative tumours combined (Group I+II), and patients with BMI1-positive tumours (Group III).

Yoshikawa et al. BMC Cancer 2012 12:461   doi:10.1186/1471-2407-12-461
Download authors' original image